A. Bertolani

发表

Implementation of Value-based Pricing for Medicines.

C. Jommi, P. Armeni, Francesco Costa, 2019, Clinical therapeutics.

Halogen bonding modulates hydrogel formation from Fmoc amino acids

P. Metrangolo, N. Demitri, D. Maiolo, 2017 .

The hospitalization burden of influenza: just the tip of the iceberg?

G. Fattore, F. Pregliasco, A. Bertolani, 2018 .

Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives

C. Jommi, C. Rognoni, A. Bertolani, 2018, Global and Regional Health Technology Assessment.

Supramolecular amplification of amyloid self-assembly by iodination

N. Houbenov, O. Ikkala, P. Metrangolo, 2015, Nature Communications.

Crystal Structure of the DFNKF Segment of Human Calcitonin Unveils Aromatic Interactions between Phenylalanines

G. Colombo, G. Morra, A. Genoni, 2016, Chemistry.

An efficient method for the lipase-catalysed resolution and in-line purification of racemic flurbiprofen in a continuous-flow reactor

Diego Romano, Lucia Tamborini, Francesco Molinari, 2012 .

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects

C. Jommi, C. Rognoni, A. Bertolani, 2021, Clinical Drug Investigation.

Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe

C. Jommi, P. Armeni, A. Bertolani, 2023, Health Policy and Technology.

Local policies on biosimilars: are they designed to optimize use of liberated resources?

C. Jommi, A. Bertolani, 2020, Generics and Biosimilars Initiative Journal.